MorphoSys, a company whose research has yielded programs placed with big pharmaceutical companies and upstart biotechs, is stopping all preclinical work to focus on cancer, particularly a late-stage drug candidate it acquired in a…
Continue Reading
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multi-year strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology. Pfizer will leverage Tempus’ library…
Continue Reading
What You Should Know:– C2i Genomics, a cancer intelligence company, today announced a collaboration with Riken Genesis Co., Ltd. (RG), a company specializing in providing the service of personalized medicine based on contract analysis…
Continue ReadingWhat You Should Know:[embedded content]– Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less…
Continue Reading
As a health economist, researcher in evidence-based medicine, and consultant to biopharma executives, I am no stranger to data. We all want more of it, to make sense of it, and to use it…
Continue Reading
GoodRx reported falling revenue for the fourth quarter, but its stock rallied early Wednesday after beating earnings expectations. The company, best known for its drug cost transparency tools, reported $184.1 million in revenue for Q4…
Continue Reading
At a time when children and families are increasingly in need of mental health support, Evernorth Health Group said it will offer behavioral health provider Brightline’s services to its employer clients.
The two companies announced…
Eli Lilly is cutting insulin prices, and this time it’s for real.
Months after a Twitter account posing as the drugmaker went viral with a tweet stating, “insulin is free now,” the company on Wednesday…
By Hannah Nelson
March 01, 2023 – The Puerto Rico Health Information Exchange (PRHIE) has announced its intention to participate in TEFCA through Health Gorilla’s anticipated Qualified Health Information Network (QHIN).
Health Gorilla is a…
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
